VILINBIO

Vilin Bio Med Share Price

 

 

Start SIP in VILINBIO

Start SIP

Performance

  • Low
  • ₹25
  • High
  • ₹25
  • 52 Week Low
  • ₹17
  • 52 Week High
  • ₹33
  • Open Price₹25
  • Previous Close₹24
  • Volume16,000
  • 50 DMA₹22.78
  • 100 DMA₹23.63
  • 200 DMA₹23.63

Investment Returns

  • Over 1 Month + 29.49%
  • Over 3 Month -1.17%
  • Over 6 Month -3.63%
  • Over 1 Year + 5.43%

Smart Investing Starts Here Start SIP with Vilin Bio Med for Steady Growth!

Invest Now

Vilin Bio Med Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 157.6
  • PEG Ratio
  • -
  • Market Cap Cr
  • 35
  • P/B Ratio
  • 1.5
  • Average True Range
  • 1.05
  • EPS
  • 0.16
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.6
  • RSI
  • 64.84
  • MFI
  • 81.36

Vilin Bio Med Financials

Vilin Bio Med Technicals

EMA & SMA

Current Price
₹25.25
+ 1.2 (4.99%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹21.86
  • 50 Day
  • ₹22.78
  • 100 Day
  • ₹23.63
  • 200 Day
  • ₹23.63

Resistance and Support

25.25 Pivot Speed
  • R3 25.25
  • R2 25.25
  • R1 25.25
  • S1 25.25
  • S2 25.25
  • S3 25.25

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Vilin Bio Med Ltd has an operating revenue of Rs. 40.28 Cr. on a trailing 12-month basis. An annual revenue de-growth of -5% needs improvement, Pre-tax margin of 2% needs improvement, ROE of 0% is poor and needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. From an O'Neil Methodology perspective, the stock has an EPS Rank of 47 which is a POOR score indicating inconsistency in earnings, a RS Rating of 52 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 71 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Vilin Bio Med Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-12 Quarterly Results
2025-10-14 Others To consider other business matters.
2025-05-17 Audited Results
2025-01-10 To consider Fund Raising & Others To consider other business matters.
2024-10-30 Quarterly Results

Vilin Bio Med F&O

Vilin Bio Med Shareholding Pattern

63.89%
33.55%
2.56%

About Vilin Bio Med

  • NSE Symbol
  • VILINBIO
  • BSE Symbol
  • Managing Director
  • Mr. Madhusudhan Yadamakanti Reddy
  • ISIN
  • INE0L4V01013

Similar Stocks to Vilin Bio Med

Vilin Bio Med FAQs

Vilin Bio Med share price is ₹25 As on 09 January, 2026 | 03:44

The Market Cap of Vilin Bio Med is ₹35.2 Cr As on 09 January, 2026 | 03:44

The P/E ratio of Vilin Bio Med is 157.6 As on 09 January, 2026 | 03:44

The PB ratio of Vilin Bio Med is 1.5 As on 09 January, 2026 | 03:44

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23